Thomas Cusack serves as Executive at HERON THERAPEUTICS, INC. /DE/, where they oversee executive responsibilities. Since joining the company, Thomas Cusack has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 30, 2026 involved receiving (via award) 53,960 shares valued at $0.
Thomas Cusack currently holds 53,960 shares of HERON THERAPEUTICS, INC. /DE/ (HRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Cusack has been a net neutral trader of HRTX stock. They have purchased $0 and sold $0 worth of shares.
Thomas Cusack's most recent insider trade was on Jan 30, 2026, when they sold 53,960 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |